Trovagene Collaborates with UCSD for EGFR Monitoring in Lung Cancer | GenomeWeb

NEW YORK (GenoemWeb) – Trovagene said today that it is collaborating with the University of California, San Diego Moores Cancer Center to determine the utility of detecting EGFR mutations in lung cancer patients using Trovagene's Precision Cancer Monitoring platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.